News Feed Opinion Blog Posts Career Updates Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
August, 2025
August 2025
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
Koschmieder: Current standard and novel targets for myelofibrosis
Photo of Steffen Koschmieder from ukaachen.de
Jun 18, 2024, 23:12

Koschmieder: Current standard and novel targets for myelofibrosis

Talha Badar shared on X:        .

“Koschmieder: current standard and novel targets for myelofibrosis in 2024!
myelofibrosis

Image

Koschmieder: novel combination trials

Image

Image

Image

Koschmieder: current standard and novel targets for myelofibrosis in 2024!”
Image

Source: Talha Badar/X

Dr. Talha Badar, MD, is a specialist in Hematology Oncology based in Mayo Clinic, Jacksonville, Florida. His primary areas of expertise include Leukemia, particularly Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), Acute Lymphoblastic Leukemia (ALL), and Bone Marrow Transplantation. Over his career, he has actively contributed to clinical research and clinical trials.

cancer Current standard EHA24 Mayo Clinic myelofibrosis novel combination trials novel targets OncoDaily Oncology Steffen Koschmieder Talha Badar
Special Coverage
Dialogues
Aug 14, 2025, 03:06
Global Health Dialogues with Princess Dina Mired: HE Said Darwazah
Dialogues
Aug 14, 2025, 03:06
How Pfizer's BRAF-TOVI Breakthrough Is Revolutionizing MCC Treatment | Dr. Susan Zhang
Dialogues
Aug 14, 2025, 03:04
Empowering Oncologists: How coaching can make a difference?
Dialogues
Aug 14, 2025, 03:04
How Are LMICs Expanding Childhood Cancer Care with Limited Resources? | Second Global Oncothon
Opinion
Aug 14, 2025, 03:03
ONCOFFEE: Aviv Philip Goncharov – Navigating Residency and Research in Oncology Across Borders
Dialogues
Aug 14, 2025, 03:01
What’s Missing in Childhood Cancer Care? Global Experts Share Unfiltered Insights
Dialogues
Aug 14, 2025, 02:59
Why Cardio-Oncology Training Matters for Oncologists Treating Patients at Risk | MASCC 2025
New Paper Alert
Aug 14, 2025, 00:38
Survival Benefit of High TMB and BRAF Mutation in Advanced Melanoma on Adjuvant Anti–PD-1
Insight
Aug 13, 2025, 21:09
Elisa Agostinetto: Patients’ and Physicians’ Perspectives on Brain Imaging Screening in Metastatic Breast Cancer
Insight
Aug 13, 2025, 21:09
Amir Manbachi: Fighting Glioblastoma with Sound Waves
Voices
Aug 13, 2025, 20:52
Chiara Corti: Ranking Oncologists in Social Media - What Could Go Wrong?
Insight
Aug 13, 2025, 20:36
Talha Badar: Brief Thread on Clonal Hematopoiesis